Avanos Medical, Inc. (AVNS) reported fourth-quarter 2023 adjusted earnings per share (EPS) from continuing operations of 36 cents, down 20% year over year. The bottom line missed the Zacks Consensus Estimate by a penny.GAAP EPS from continuing operations in the quarter under review was 24 cents, up 14.3% year over year.Full-year adjusted EPS was $1.03, up 3% compared with that at the end of the comparable 2022 period. The figure lagged the Zacks Consensus Estimate by 0.9%.RevenuesRevenues grossed $173.3 mil ...